» Articles » PMID: 37099129

Curcumin Attenuates Hydroxychloroquine-mediated Apoptosis and Oxidative Stress Via the Inhibition of TRPM2 Channel Signalling Pathways in a Retinal Pigment Epithelium Cell Line

Overview
Specialty Ophthalmology
Date 2023 Apr 26
PMID 37099129
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Hydroxychloroquine (HCQ) is used in the treatment of several diseases, such as malaria, Sjögren's disease, Covid-19, and rheumatoid arthritis. However, HCQ induces retinal pigment epithelium death via the excessive increase of cytosolic (cROS) and mitochondrial (mROS) free oxygen radical production. The transient receptor potential melastatin 2 (TRPM2) cation channel is stimulated by ADP-ribose (ADPR), cROS, and mROS, although it is inhibited by curcumin (CRC). We aimed to investigate the modulating action of CRC on HCQ-induced TRPM2 stimulation, cROS, mROS, apoptosis, and death in an adult retinal pigment epithelial 19 (ARPE19) cell line model.

Material And Methods: ARPE19 cells were divided into four groups: control (CNT), CRC (5 µM for 24 h), HCQ (60 µM for 48 h), and CRC + HCQ groups.

Results: The levels of cell death (propidium iodide positive cell numbers), apoptosis markers (caspases -3, -8, and -9), oxidative stress (cROS and mROS), mitochondria membrane depolarization, TRPM2 current density, and intracellular free Ca and Zn fluorescence intensity were upregulated in the HCQ group after stimulation with hydrogen peroxide and ADPR, but their levels were downregulated by treatments with CRC and TRPM2 blockers (ACA and carvacrol). The HCQ-induced decrease in retinal live cell count and cell viability was counteracted by treatment with CRC.

Conclusion: HCQ-mediated overload Ca influx and retinal oxidative toxicity were induced in an ARPE19 cell line through the stimulation of TRPM2, although they were attenuated by treatment with CRC. Hence, CRC may be a potential therapeutic antioxidant for TRPM2 activation and HCQ treatment-induced retinal oxidative injury and apoptosis.

Citing Articles

Target in Sight: A Comprehensive Review of Hydroxychloroquine-Induced Bull's Eye Maculopathy.

Snow Z, Seely K, Barrett S, Pecha J, Goldhardt R Curr Ophthalmol Rep. 2024; 12(3):38-48.

PMID: 39371107 PMC: 11452169. DOI: 10.1007/s40135-024-00321-6.


Unveiling the role of CaMKII in retinal degeneration: from biological mechanism to therapeutic strategies.

Sun Y, Hao M, Wu H, Zhang C, Wei D, Li S Cell Biosci. 2024; 14(1):59.

PMID: 38725013 PMC: 11084033. DOI: 10.1186/s13578-024-01236-2.


Cell death induction and protection by activation of ubiquitously expressed anion/cation channels. Part 3: the roles and properties of TRPM2 and TRPM7.

Okada Y, Numata T, Sabirov R, Kashio M, Merzlyak P, Sato-Numata K Front Cell Dev Biol. 2023; 11:1246955.

PMID: 37842082 PMC: 10576435. DOI: 10.3389/fcell.2023.1246955.

References
1.
Dima A, Jurcut C, Arnaud L . Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?. Joint Bone Spine. 2021; 88(3):105143. DOI: 10.1016/j.jbspin.2021.105143. View

2.
Ferreira P, de Sousa R, Ferreira J, Militao G, Bezerra D . Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms. Pharmacol Res. 2021; 168:105582. DOI: 10.1016/j.phrs.2021.105582. View

3.
Hsu S, Ponugoti A, Deaner J, Vajzovic L . Update on Retinal Drug Toxicities. Curr Ophthalmol Rep. 2021; 9(4):168-177. PMC: 8688906. DOI: 10.1007/s40135-021-00277-x. View

4.
Doyno C, Sobieraj D, Baker W . Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. Clin Toxicol (Phila). 2020; 59(1):12-23. DOI: 10.1080/15563650.2020.1817479. View

5.
Ding H, Denniston A, Rao V, Gordon C . Hydroxychloroquine-related retinal toxicity. Rheumatology (Oxford). 2015; 55(6):957-67. DOI: 10.1093/rheumatology/kev357. View